Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1167.6000 -5.10 (-0.43%)
NSE Jan 19, 2026 15:31 PM
Volume: 546.7K
 

1167.60
-0.43%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. has an average target of 1349.22 from 9 brokers.
More from Aurobindo Pharma Ltd.
Recommended